Cosentini, Deborah
 Distribuzione geografica
Continente #
NA - Nord America 1.957
EU - Europa 1.316
AS - Asia 857
SA - Sud America 7
AF - Africa 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.144
Nazione #
US - Stati Uniti d'America 1.943
PL - Polonia 314
IT - Italia 300
SG - Singapore 284
CN - Cina 210
HK - Hong Kong 182
DE - Germania 145
FI - Finlandia 143
UA - Ucraina 86
IE - Irlanda 77
RU - Federazione Russa 68
TR - Turchia 65
CZ - Repubblica Ceca 39
GB - Regno Unito 38
ID - Indonesia 36
SE - Svezia 29
VN - Vietnam 28
BE - Belgio 26
IN - India 25
FR - Francia 21
JP - Giappone 15
CA - Canada 11
NL - Olanda 10
CH - Svizzera 9
PT - Portogallo 4
AZ - Azerbaigian 3
AR - Argentina 2
CL - Cile 2
CR - Costa Rica 2
TH - Thailandia 2
TW - Taiwan 2
ZW - Zimbabwe 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 4.144
Città #
Warsaw 314
Fairfield 275
Singapore 254
Ashburn 191
Hong Kong 181
Chandler 157
Helsinki 133
Seattle 119
Woodbridge 111
Houston 106
New York 96
Wilmington 79
Cambridge 78
Jacksonville 76
Princeton 69
Istanbul 65
Brescia 47
Ann Arbor 43
Dublin 43
Boardman 41
Moscow 41
Beijing 40
Munich 40
Jakarta 36
Shanghai 36
Dalmine 34
Brno 32
Los Angeles 30
West Jordan 30
Dong Ket 28
Brussels 26
Milan 26
Menlo Park 22
Dearborn 20
Romola 20
Nanjing 16
Naples 16
Rome 13
San Diego 13
Pune 12
Washington 11
Des Moines 10
Gumyojicho 9
London 9
Turin 9
Nanchang 8
Lappeenranta 7
Mumbai 7
Changsha 6
Fukuoka 6
Jinan 6
Olomouc 6
Chicago 5
Dietikon 5
Perugia 5
San Francisco 5
Shenyang 5
Tianjin 5
Hebei 4
Leipzig 4
Livorno 4
Phoenix 4
Redwood City 4
Barberino di Mugello 3
Espoo 3
Falkenstein 3
Gardone Val Trompia 3
Genoa 3
Guangzhou 3
Lisbon 3
North York 3
Norwalk 3
Ottawa 3
Rockville 3
Toronto 3
Zhengzhou 3
Augusta 2
Baku 2
Bergamo 2
Berlin 2
Borås 2
Brooklyn 2
Buenos Aires 2
Bussolengo 2
Chiswick 2
Cornuda 2
Fuzhou 2
Giussano 2
Gradara 2
Gunzenhausen 2
Hounslow 2
Huizen 2
Kunming 2
Leawood 2
Ma'anshan 2
Melfi 2
New Bedfont 2
Parma 2
Pianello del Lario 2
Poli 2
Totale 3.240
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 194
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 179
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 177
Immunotherapy failure in adrenocortical cancer: where next? 167
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 157
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 153
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 151
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 132
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 126
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 126
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 113
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 111
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 110
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 109
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 103
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 98
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 86
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 85
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 83
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 75
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 69
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 63
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 63
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 56
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 54
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 52
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 51
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 50
null 50
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 49
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 49
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 44
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 44
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 42
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 41
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 39
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 39
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 39
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 36
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 35
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 35
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 35
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 35
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 34
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 32
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 32
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 31
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 31
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 31
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 30
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 29
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 28
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 27
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 25
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 25
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 25
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 25
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 23
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 23
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 22
The Evolving Treatment Landscape of Medullary Thyroid Cancer 20
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 19
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 18
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 18
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 15
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 15
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 14
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 13
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 13
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial 13
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 11
Adjuvant denosumab for early breast cancer-Evidence and controversy 10
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 9
Real-world use of multigene signatures in early breast cancer: differences to clinical trials 9
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 7
Totale 4.282
Categoria #
all - tutte 28.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020395 0 0 0 0 0 0 75 79 66 70 47 58
2020/2021768 35 88 72 91 67 74 32 68 48 88 38 67
2021/2022398 37 10 12 76 19 27 15 20 17 55 31 79
2022/2023440 50 22 27 31 36 96 4 48 56 16 29 25
2023/2024918 43 31 74 75 74 171 27 50 129 61 23 160
2024/2025928 54 45 30 414 174 131 80 0 0 0 0 0
Totale 4.282